Aave’s Avon Acquisition: Fixed Rates Would Not Fix Collateral Risk

A borrower can know the interest rate on a loan and still lose collateral before repayment is due. That distinction matters as Aave Labs develops fixed-rate lending capabilities following its acquisition of Avon: a predictable borrowing rate would not, by itself, protect a position against falling collateral values.

Aave Labs announced on November 6, 2026 that it had acquired Avon’s team and technology, including lending protocols and an onchain order book. The announcement describes work on new capabilities such as fixed-rate lending. It does not establish a launch date or final borrower terms. (Aave Labs’ acquisition announcement)

The Aave Avon acquisition therefore raises two separate questions. What uncertainty could a fixed rate remove? And what risks would remain in the loan securing it?

Start with the borrowing mechanics

Aave’s borrowing guide describes a collateral-backed system: users must supply adequate collateral to support their debt. Its documented variable borrowing rates adjust as liquidity is borrowed or repaid, with utilisation and governance-set parameters influencing the rate. Utilisation describes how much of the available lending liquidity is being used. (Aave borrowing guide)

For a borrower, this creates uncertainty about future interest expense. The rate at the moment of borrowing is not necessarily the rate that will apply throughout the position’s life.

Collateral introduces a different uncertainty. Aave V3 expresses the relationship between collateral and debt through a *health factor*: liquidation-weighted collateral value divided by debt value. The weighting reflects the liquidation thresholds applicable to the collateral, rather than treating its entire market value as an unrestricted borrowing cushion. A health factor below 1 makes a position eligible for liquidation. (Aave V3 health-factor documentation)

Liquidation is the protocol’s mechanism for resolving a position that no longer meets its collateral requirements. Crucially, eligibility is a boundary defined by the lending rules—not a promise that a borrower can keep the position open until a preferred repayment date.

These mechanics explain why the interest rate and the collateral cushion cannot be treated as interchangeable measures of safety. Interest affects how debt develops. Collateral valuation and liquidation thresholds determine how much debt the position can support.

What fixing the rate would actually change

If a future product locked a borrowing rate for a defined period, it could make the interest calculation more predictable over that period. The scope of that predictability would depend on the contract: the duration of the rate commitment, how interest accrues and which fees sit outside the quoted rate.

It would not freeze the value of the assets securing the loan.

Consider a hypothetical collateral-backed loan with an unchanged interest rate. If the collateral’s value falls while the debt remains unchanged, the collateral-to-debt relationship deteriorates. Under a health-factor system such as Aave V3’s, that decline can bring the position closer to liquidation even though there has been no rate increase.

Interest can also continue to accrue at a fixed rate. “Fixed” describes the rate, not necessarily a constant outstanding balance.

That is an analytical distinction, not a prediction about Avon-derived products. Aave’s existing V3 documentation provides the baseline mechanics; it does not establish that a future fixed-rate offering would use the same collateral rules, thresholds or liquidation process.

Aave fixed-rate lending could address a real source of uncertainty. But describing that improvement as safer borrowing without specifying the remaining conditions would overstate what a rate commitment can achieve.

Five questions the product terms would need to answer

The acquisition supplies a development direction. Assessing an actual product would require more granular evidence.

How long would the rate remain fixed? A maturity date is when repayment becomes due. Would the rate commitment last until that date, cover only an initial period, or depend on other conditions? What would happen to unpaid debt at maturity? A fixed rate would not establish a right to renew the loan on the same terms.

What would an early exit involve? Early repayment by a borrower and early withdrawal by a lender are different operations. Could either party leave before maturity, and at what cost? If an exit depended on transferring a position to another participant, its availability would depend on someone accepting the other side. An onchain order book—a record of trading orders maintained on a blockchain—would not, merely by existing, demonstrate sufficient trading liquidity. Avon’s order-book technology is part of the announced acquisition, not evidence of guaranteed exits. (Acquisition scope)

Which collateral and liquidation rules would apply? The necessary detail would include eligible assets, valuation methods, liquidation thresholds and the treatment of accrued interest. Another important question is whether liquidation could occur before maturity. A scheduled repayment date and protection against earlier liquidation are separate contractual properties.

What security evidence would cover the deployed system? Relevant evidence would identify which smart contracts were reviewed, which code versions the reviews covered, what issues were found and whether they were resolved. Smart contracts are the blockchain-executed software implementing the product’s rules. A security review of one component would not, on its own, establish the security of every integration or later modification. These are assessment questions, not claims that a particular review has or has not occurred.

What approvals and execution steps would be required? Where implementation involved changes to Aave Protocol, the relevant governance record would matter. Aave’s documentation distinguishes proposal discussion, voting and execution, and explains that proposals can introduce features or modify parameters. An acquisition announcement is not evidence that those steps have occurred. (Aave governance proposals)

None of these questions identifies an announced feature or a demonstrated defect. They identify the information needed to move from a development announcement to an assessment of a working lending product.

The acquisition is not the implementation

Aave Labs acquiring a team and technology is a corporate event. Deploying contracts, establishing market terms and executing any required protocol governance changes are separate events. The supplied announcement does not establish an Avon-specific governance proposal or a completed fixed-rate rollout.

The useful test of future progress will therefore be narrower than whether “fixed rate” appears in a product description. It will be whether the documentation makes clear what is fixed, for how long, how a position can end and what can trigger the loss of collateral along the way.

Borrowing-cost predictability would be a meaningful capability. It would remain one part of the loan—not a substitute for collateral protection, exit liquidity or secure implementation.

Research method and limitations

This analysis uses desk research from the supplied verified Aave Labs announcement and official Aave documentation, with a research cutoff of November 9, 2026. These are first-party sources. No contracts, order-book liquidity or liquidation execution were independently tested. Existing V3 mechanics are used as background, not as confirmed terms of a future Avon-derived product.

Sources and References

• Aave Labs: Aave Labs Acquires Avon, November 6, 2026 — acquisition scope and development direction.
• Aave: Borrow Tokens, undated; supplied research accessed November 9, 2026 — collateral requirements and variable borrowing-rate mechanics.
• Aave V3: Health Factor, undated; supplied research accessed November 9, 2026 — health-factor calculation and liquidation eligibility.
• Aave: Proposals, undated; supplied research accessed November 9, 2026 — protocol governance discussion, voting and execution.